NCT02724202View on ClinicalTrials.gov

Curcumin in Combination With 5FU for Colon Cancer

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 13, 2020

Study Completion Date

June 13, 2020

Conditions
Metastatic Colon Cancer
Interventions
DRUG

Curcumin

Curcumin is supplied as soft-gel capsule. It is a micronized rhizome extract containing phospholipids and 500mg of pure curcuminoids (95% curcumin, 5% desmethoxycurcumin) suspended in turmeric essential oil.

DRUG

5-flurorouracil

Fluorouracil is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. Fluorouracil is classified as an antimetabolite.

Trial Locations (1)

75246

Baylor Charles A. Sammons Cancer Center, Dallas

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER